Perspective Therapeutics Inc (CATX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2021 | 06-2020 | 06-2019 | 06-2018 | 06-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 63,828 | 2,392 | 5,326 | 2,600 | 5,932 |
| Marketable Securities | N/A | N/A | N/A | 825 | N/A |
| Receivables | 2,013 | 2,044 | 1,154 | 1,192 | 726 |
| Inventories | 980 | 645 | 530 | 494 | 323 |
| Other current assets | 0 | 0 | 0 | 0 | 3,039 |
| TOTAL | $67,302 | $5,507 | $7,315 | $5,446 | $10,291 |
| Non-Current Assets | |||||
| PPE Net | 1,958 | 1,735 | 1,609 | 1,311 | 1,054 |
| Other Non-Current Assets | 1,156 | 1,457 | 498 | 698 | 924 |
| TOTAL | $3,114 | $3,192 | $2,107 | $2,009 | $1,978 |
| Total Assets | $70,416 | $8,699 | $9,422 | $7,455 | $12,269 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 730 | 654 | 683 | 1,391 | 630 |
| Accrued Expenses | 819 | 685 | 438 | 444 | 476 |
| TOTAL | $1,801 | $1,575 | $1,121 | $1,835 | $1,106 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,209 | 1,401 | 621 | 590 | 561 |
| TOTAL | $1,209 | $1,401 | $621 | $590 | $561 |
| Total Liabilities | $3,010 | $2,976 | $1,742 | $2,425 | $1,667 |
| Shareholders' Equity | |||||
| Common Shares | 142 | 69 | 67 | 56 | 55 |
| Retained earnings | -91,325 | -87,938 | -84,492 | -79,348 | -72,604 |
| TOTAL | $67,406 | $5,723 | $7,680 | $5,030 | $10,602 |
| Total Liabilities And Equity | $70,416 | $8,699 | $9,422 | $7,455 | $12,269 |